Absorption and antioxidant effects of quercetin from onions, in man

European Journal of Clinical Nutrition

Volumn 53, Issue 2, 1999, Pages 92-96

  McAnlis, G T ^a   McEneny, J ^a   Pearce, J ^a   Young, I S ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Flavonoids; Low density lipoprotein; Onions; Quercetin

Indexed keywords

ALBUMIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PROTEIN; QUERCETIN; VERY LOW DENSITY LIPOPROTEIN;

ABSORPTION; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING AFFINITY; BLOOD LEVEL; CONTROLLED STUDY; DIET; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; MALE; NORMAL HUMAN; ONION;

ALLIUM CEPA;

EID: 0033067923     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600682     Document Type: Article

References (34)

1. de-Whalley C, Rankin SM, Hoult JRS, Jessup W & Leake DS (1990): Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol. 39, 1743-1750.
2. Frankel EN, Kanner J, German JB, Parks E & Kinsella JE (1993): Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341, 454-457.
3. Fuhrman B, Lavy A & Aviram M (1995): Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. Soc. Clin. Nutr. 61, 549-554.
4. Goldstein JL, Ho YK, Basu SK & Brown MS (1979): Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. 76, 333-337.
5. Gugler R, Leschik M & Dengler HJ (1975): Disposition of quercetin in man after single oral and intravenous doses. E. J. Clin. Pharm. 9, 229-234.
6. Hertog MGL, Hollman PCH & Katan MB (1992): Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in The Netherlands. J. Agric. Food Chem. 40, 2379-2383.
7. Hertog MGL, Hollman PCH & Putte B (1993a): Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J. Agric. Food Chem. 41, 1242-1246.
8. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB & Kromhout D (1993b): Dietary antioxidant flavonoids and risk of coronary heart disease: the zutphen elderly study. Lancet 342, 1007-1011.
9. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, Fidanza F, Giampaoli S, Jansen A, Menotti A, Nedeljkovic S, Pekkarinen M, Simic BS, Toshima H, Feskens EJM, Hollman PCH & Katan MB (1995): Flavonoid intake and long-term risk of coronary-heart-disease and cancer in the 7 countries study. Arch. Int. Med. 155, 381-386.
10. Hertog MGL, Sweetnam PM, Fehily AM, Elwood PC & Kromhout D (1997): Antioxidant flavonoids and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am. J. Clin. Nutr. 65, 1489-1494.
11. Hollman PCH, Vries JHM, Leeuwen SD, Mengelers MJB & Katan MB (1995): Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nut. 62, 1276-1282.
12. Hollman PCH, Vantrijp JMP & Buysman MNCP (1996): Fluorescence detection of flavonols in HPLC by postcolumn chelation with aluminum. Anal. Chem. 68, 3511-3515.
13. van het Hof K, de Boer HSM, Wiseman SA, Lien N, Weststrate JA & Tijburg LBM (1997): Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans Am. J. Clin. Nut. 66, 1125-1132.
14. Igarashi K & Ohmuma M (1995): Effect of Isohamneti, Rhamnetin, and Quercetin on the concentrations of cholesterol and lipoperoxide in the serum and liver and on the blood and liver antioxidative enzyme activities in rats. Biosci. Biotech. Biochem. 59, 595-601.
15. Keli SO, Hertog MGL, Feskens EJM & Kromhout D (1996): Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch. Int. Med. 156, 637-642.
16. Kiviranta J, Huovinen K & Hiltunen R (1988): Variation of phenolic substances in onion. Acta Pharm. Fenn. 97, 67-72.
17. Knekt P, Jarvinen R, Reunanen A & Maatela J (1996): Flavonoid intake and coronary mortality in Finland: a cohort study. Br. Med. J. 312, 478-481.
18. Kuhnau J (1976): The Flavonoids: A class of semi-essential food components; their role in human nutrition. World Rev. Nutr. Diet 24, 117-191.
19. Laughton MJ, Evans PJ, Moroney MA, Hoult JRS & Halliwell B (1991): Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Biochem. Pharmacol. 42, 1673-1681.
20. Lee MJ, Wang ZY, Li H, Sun Y, Gobbo S, Balentine DA & Yang CS (1995): Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers and Prevention 4, 393-399.
21. McAnlis GT, McEneny J, Pearce J & Young IY (1997): The effect of various dietary flavonoids on the susceptibility of low density lipoproteins to oxidation in vitro using both metallic and non-metallic oxidising agents. Biochem. Soc. Trans. 25, 142S.
22. McAnlis GT, McEneny J, Pearce J & Young IY (1998): Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur. J. Clin Nut. 52, 202-206.
23. McDowell IFW, McEneny J & Trimble ER (1995): A rapid method for measurement of the susceptibility to oxidation of LDL. Clin. Biochem. 32, 167-174.
24. Miller NJ & Rice-Evans CA (1996): Spectrophotometric determination of antioxidant activity. Redox Report. 2, 161-171.
25. Morel I, Lescoat G, Cogrel P & Cillard J (1993): Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol. 45, 13-19.
26. Nieder M (1991): Pharmakokinetik der Ginkgo-flavonole im plasma. Munch Med Wochenschr 133, S61-S62.
27. Nyyssonen K, Porkkala-Sarataho E, Kaikkonen J & Salonen JT (1997): Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men. Atherosclerosis 130, 223-233.
28. Princen HMG, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LBM, Langius JAE, Meinders AE & Pijl H (1998): No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscl. Thromb. Vasc. Biol. 18, 833-841.
29. Rankin SM, De Whalley CV, Hoult JRS, Jessup W, Wilkins GM, Collard J & Leake DS (1993): The modification of low density lipoprotein by the flavonoids myricetin and gossypetin. Biochem. Pharmacol. 45, 67-75.
30. Rice-Evans CA, Miller NJ, Paganga G (1996): Structure-antioxidant activity relationships of flavonoids and phenolic acids. Ree Rad. Biol. Med. 20, 933-956.
31. Rimm EB, Katan MB, Ascerio A, Stampfer MJ & Willet WC (1996): Relation between intake of flavonoids and risk of coronary heart disease in male health professionals. Ann. Intern. Med. 125, 384-389.
32. Serafini M, Ghiselli A & Ferro-Luzzi A (1996): In vivo antioxidant effect of green and black tea in man. Eur. J. Clin. Nut. 50, 28-32.
33. Steinberg D, Parthasarathy S, Carew TE, Khoo JC & Witztum JL (1989): Beyond cholesterol. New England J. Med. 320, 915-924.
34. Whitehead TP, Thorpe GHG & Maxwell SRJ (1992): Enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Anal. Chem. 266, 265-277.